Skip to main content

Abuse of Performance-Enhancing Drugs

  • Reference work entry
Neuroscience in the 21st Century

Abstract

Anabolic-androgen steroids (AASs) are the primary drug class in a larger pattern of drug use designed to improve one’s appearance or alter their ability to perform in athletic or other competitive environments. The use of these substances has evolved tremendously in the last century. The evolution of this form of drug use has been aided by the advancements in the understanding of the basic neuroscience of androgen effects in the central nervous system (CNS). This chapter summarizes the current knowledge on the psychiatric effects of AASs and the theoretical and preclinical models that support the possibility for AAS intoxication and dependence. Emerging evidence suggests that these two aspects of AAS use are mediated by distinct neuroendocrine events involving drug metabolism into other active androgens or estrogens and the ability of AASs to stimulate natural opiates and inhibit stress response. This latter effect is also linked to the neuroendocrine effects of intense exercise, which are mimicked by AAS use. Future directions for preclinical, translational, and clinical research are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Clark AS, Henderson LP (2003) Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Biobehav Rev 27(5):413–436

    Article  PubMed  CAS  Google Scholar 

  • Hildebrandt T, Langenbucher JW, Carr SJ et al (2007) Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users. J Abnorm Psychol 116(4):717–733

    Article  PubMed  Google Scholar 

  • Hildebrandt T, Lai JK, Langenbucher JW et al (2011) The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug Alcohol Depend 114(1):1–11

    Article  PubMed  Google Scholar 

  • Kanayama G, Brower KJ, Wood RI et al (2009) Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 104(12):1966–1978

    Article  PubMed  Google Scholar 

  • Kicman AT (2008) Pharmacology of anabolic steroids. Br J Pharmacol 154(3):502–521

    Article  PubMed  CAS  Google Scholar 

  • McGinnis MY (2004) Anabolic androgenic steroids and aggression: studies using animal models. Ann N Y Acad Sci 1036:399–415

    Article  PubMed  CAS  Google Scholar 

  • Peters KD, Wood RI (2005) Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience 130(4):971–981

    Article  PubMed  CAS  Google Scholar 

  • Wood RI (2008) Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol 29(4):490–506

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tom Hildebrandt .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this entry

Cite this entry

Hildebrandt, T. (2013). Abuse of Performance-Enhancing Drugs. In: Pfaff, D.W. (eds) Neuroscience in the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1997-6_109

Download citation

Publish with us

Policies and ethics